Search

The U.S., Britain, Canada and others are hedging their bets, reserving doses that far outnumber their populations, as many poorer nations struggle to secure enough. As a growing number of [...]

The Trump administration is discussing helping the drug maker get the raw materials it would need to produce tens of millions of extra doses of its Covid-19 vaccine in the [...]

An initial shipment of about 2.9 million doses of the vaccine will be sent around the United States over the next week. The Food and Drug Administration authorized Pfizer's Covid-19 [...]

The blessing of these experts means that the agency will likely OK the vaccine's use, paving the way for health care workers to begin getting shots next week. Pfizer's Covid-19 [...]

The pharmaceutical company offered the government a chance to lock in additional supplies before its vaccine was proved effective in clinical trials. WASHINGTON -- Before Pfizer's coronavirus vaccine was proved [...]

Byline: Sharon LaFraniere, Katie Thomas, Noah Weiland, David Gelles, Sheryl Gay Stolberg and Denise Grady WASHINGTON - The call was tense, the message discouraging. Moncef Slaoui, the head of the [...]

The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the [...]

WASHINGTON -- The call was tense, the message discouraging. Moncef Slaoui, the head of the Trump administration's effort to quickly produce a vaccine for the coronavirus, was on the phone [...]

A large team of regulators at the agency will take about three weeks to review an application spanning thousands of pages. The drug maker Pfizer said on Friday that it [...]

Byline: Katie Thomas Front-runners in the coronavirus vaccine race won't make nearly as many doses this year as were predicted, but they may kick into high gear next year. The [...]

The company said it planned to apply for emergency approval from the Food and Drug Administration ''within days.'' The drug maker Pfizer said on Wednesday that its coronavirus vaccine was [...]

Front-runners in the coronavirus vaccine race won't make nearly as many doses this year as were predicted, but they may kick into high gear next year. The promising news that [...]

As coronavirus cases surge in the United States and elsewhere, the world got good news on Monday. Pfizer and its partner, the German company, BioNTech, announced preliminary results that suggested [...]

The drug maker Pfizer announced on Monday that an early analysis of its coronavirus vaccine trial suggested the vaccine was robustly effective in preventing Covid-19, a promising development as the [...]

What's the big deal? Was it part of Operation Warp Speed? When can you get one? As coronavirus cases surge in the United States and elsewhere, with little relief in [...]

Gilead Sciences said Wednesday that remdesivir, which has been authorized for emergency use since the spring, brought in $873 million in revenues so far this year. The United States reached [...]

Pfizer's C.E.O. said on Tuesday that much-anticipated results from its vaccine trial would not be coming this month, after all. After weeks of dangling the possibility of coronavirus vaccine results [...]

All the weak points of American health care -- testing delays, communication breakdowns, inequity -- are working against this potential treatment. Nearly two weeks ago, President Trump told Americans that [...]

Friday's announcement represents a shift in tone for the company and its leader, who has repeatedly emphasized the month of October in interviews and public appearances. The chief executive of [...]

Byline: Jesse Drucker, David Gelles and Katie Thomas Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug [...]

Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug prices. For a long time, drug makers have [...]

The drugmaker's experimental antibody treatment is similar to the one President Trump received from Regeneron. A government-sponsored clinical trial that is testing an antibody treatment for Covid-19 developed by the [...]

Byline: Katie Thomas and Denise Grady The president raised the drug's company's profile by calling its drug a miraculous cure -Â but also sowed suspicion about whether the treatment really [...]

The president raised the drug's company's profile by calling its drug a miraculous cure -- but also sowed suspicion about whether the treatment really works. When President Trump promoted an [...]

Byline: Katie Thomas Mr. Trump's physician has given an incomplete, upbeat picture of his health. Medical experts warn that the president is entering a pivotal, unpredictable phase. Standing on the [...]

The drug maker Regeneron said on Wednesday evening that it had submitted an application to the Food and Drug Administration for emergency approval of the experimental antibody cocktail that President [...]

In a video on Wednesday evening, the president portrayed an unproven antibody cocktail being developed by the drug maker Regeneron as a miracle cure. President Trump claimed on Wednesday that [...]

Mr. Trump's physician has given an incomplete, upbeat picture of his health. Medical experts warn that the president is entering a pivotal, unpredictable phase. Standing on the steps of Walter [...]

Byline: Katie Thomas and Roni Caryn Rabin Many of the measures cited by his doctors are reserved for patients severely affected by the coronavirus. President Trump's doctors offered rosy assessments [...]

Many of the measures cited by his doctors are reserved for patients severely affected by the coronavirus. President Trump's doctors offered rosy assessments of his condition on Sunday, but the [...]

Mr. Trump received a single dose of an antibody cocktail made by the biotech Regeneron. The company's C.E.O. has known the president for years. President Trump has received a dose [...]

Despite slim chances that its vaccine will be ready by October, Pfizer has big incentives to hint that it might be. In media appearances and talks with investors, Pfizer's chief [...]

The Maryland company, which has never brought a vaccine to market, has started its Phase 3 trial in the United Kingdom, with plans to begin in the United States in [...]

Unlike some of its competitors, Johnson & Johnson's vaccine does not need to be frozen and may require just one shot instead of two. The feverish race for a coronavirus [...]

Despite the president's repeated claims that a vaccine will be available in October, scientists, companies and federal officials all say that most people won't get one until well into next [...]

The companies hope to earn the trust of the public and of scientists who have clamored for details of the studies. Two drug companies that are leading the race to [...]

Despite the president's statements about military involvement in the vaccine rollout, officials said that for most people, ''there will be no federal official who touches any of this vaccine.'' Federal [...]

Researchers say drug companies need to be more open about how vaccine trials are run to reassure Americans who are skittish about getting a coronavirus vaccine. The morning after the [...]

The company said tests of its vaccine would start up again in Britain while remaining suspended in the U.S. and other countries. Pfizer, a competitor, announced an expansion of its [...]

The company halted late-stage trials of its coronavirus vaccine because of a serious suspected adverse reaction in a participant. The pharmaceutical company AstraZeneca halted large, late-stage global trials of its [...]

The statement is meant to reassure the public that the companies will not seek a premature approval of vaccines under pressure from the Trump administration. A group of drug companies [...]

As President Trump pushes the possibility of a vaccine this year, the C.D.C. has outlined technical scenarios to state public health officials for an unidentified Vaccine A and Vaccine B. [...]

The agency's chief spokeswoman, Emily Miller, was removed from her position just 11 days into the job. And the contract was terminated of a consultant who had advised the F.D.A. [...]

Many experts -- including a scientist who worked on the Mayo Clinic study -- were bewildered about where a key statistic came from. At a news conference on Sunday announcing [...]

The move came on the eve of the Republican convention and after President Trump pressed the agency to move faster to address the pandemic. The Food and Drug Administration on [...]

Antibody trials sponsored by Regeneron and Eli Lilly are off to a slow start because of a dearth of tests, overwhelmed hospitals and reluctant patients. As the coronavirus pandemic continues [...]

Thousands of Covid-19 patients have been treated with blood plasma outside of rigorous clinical trials -- hampering research that would have shown whether the therapy worked. An American Airlines flight [...]

The company has received a $1.6 billion grant from the government's Operation Warp Speed to have 100 million doses ready by early 2021. Novavax, the little-known Maryland company that received [...]

Operation Warp Speed has moved along at a rapid clip. But some people involved in the process fear pressure to deliver an October surprise for President Trump. In April, with [...]

President Trump is trying to revive a 2016 campaign promise to control the rising price of medicines, but new executive orders are coming when he needs drugmakers to deliver coronavirus [...]